Mesa Laboratories, Inc. (MLAB) Raises Quarterly Dividend 6.7% to $0.16; 1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Mesa Laboratories (MLAB) Acquires PCD Business of PCD-LLC
October 15, 2014 2:08 PM EDTMesa Laboratories (NASDAQ: MLAB) announced the acquisition of substantially all of the assets and certain liabilities of the process challenge device business (the "PCD Business") from PCD Process Challenge Devices, LLC, a California company ("PCD-LLC").
The acquisition of the PCD Business is expected to add approximately $2,800,000 to Mesa's revenues and to be accretive to its diluted net income per share during the first twelve months. For additional information on the acquisition, please refer to Mesa's filings on Forms 8-K and 10-Q.
PCD-LLC sources biological indicators ("BIs") of known resistance from a variety of... More



